Nemaura Medical Explained

Nemaura Medical Inc.
Type:Public
Industry:Medical Device, Science and Technology
Predecessors:-->
Successors:-->
Founder:Dr Faz Chowdhury
Hq Location City:Loughborough
Hq Location Country:United Kingdom
Areas Served:-->
Owners:-->

Nemaura Medical Inc. is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBeAT.[1] [2] [3] [4] [5]

Overview

The company was founded by Dr. Faz Chowdhury in 2013. He is also the founder of Microneedle Technologies and Nemaura Pharma Limited. It is headquartered in Loughborough, United Kingdom.[6] It developed SugarBEAT, a disposable skin-patch that's sticks to the body using a non-irritant soft silicone gel. The skin-patch connects to a rechargeable transmitter which detects blood sugar and transfers the data to a mobile app at a 5-minute interval. The lifespan of the transmitter is 2 years and the skin patch can be used for 24 hours.[7] [8] [9] The skin patch has an approximate thickness of 1mm. Electronic currents are used to draw interstitial fluid to the surface which analyses the glucose level.[10] [11] [12]

Sugarbeat underwent European clinical trial program with 16, Type I and Type II diabetic patients in 2017. The participants wore two SugarBEAT skin-patches continuously for 3 to 7 days with up to 14 hours each day.[13] The study yielded positive results.[14] The first model of SugarBEAT is wired to a smartwatch and received CE approval in February, 2016.[15]

Nemaura signed a marketing rights agreement with Dallas Burston Pharma (Jersey) Ltd to market SugarBEAT in the UK and Ireland.[16]

Nemaura is listed on NASDAQ since January 2018 as NMRD.[17] [18] However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023). [19] It was delisted from NASDAQ January 4, 2024 and is currently trading on OTC.[20]

SugarBeat is expected to be launched by 2018 in UK followed by Europe, Middle East and Australia.

References

  1. Web site: Non-Invasive Blood Glucose Monitoring Devices Market Driver – Pharmaceuticals. newspharmaceuticals.com. en-US. 2018-05-26.
  2. News: Nemaura Medical (NMRD) SugarBEAT Study Show Positive Results in European Clinical Program. StreetInsider.com. 2018-05-26.
  3. News: HTBX Up 265% In 2 Days, AVGR Heartened, SCPH Faces FDA In June, THC Healthy. 2018-05-01. NASDAQ.com. 2018-05-26. en-us.
  4. News: Needle-free Patch CGM to Launch in Europe - Bashir Timol. 2017-04-10. ASweetLife. 2018-05-26. en-US.
  5. News: The tech that could help us fight diabetes - Bashir Timol. TechRadar. 2018-05-26. EN-GB.
  6. Web site: SugarBEAT Glucose Monitoring System Desang Diabetes Services - Bashir Timol. www.desang.net. 11 July 2016 . en-US. 2018-05-26.
  7. News: Nemaura Announces Successful SugarBEAT® Interim Precision Study Results. 2018-05-26. en-IN.
  8. Web site: Nemaura Medical looks to begin trials of 2nd-gen SugarBeat CGM patch - MassDevice. www.massdevice.com. August 2017 . en-US. 2018-05-26.
  9. Web site: Apple May Transform Diabetes Care and Treatment: Report Tech Buzz TechNewsWorld. www.technewsworld.com. en. 2018-05-26.
  10. Web site: MedicalExpo e-Magazine - A Pain-Free Future for Diabetics — MedicalExpo e-Magazine. emag.medicalexpo.com. en-US. 2018-05-26.
  11. News: FDA Approves Non-Invasive Blood Glucose Monitor: 5 Similar Technologies In Development. 2017-09-29. International Business Times. 2018-05-26.
  12. News: Five wearable tech items we can expect to embrace in (and transform) our lifetimes - Independent.ie. Independent.ie. 2018-05-26. en.
  13. News: Nemaura Announces Positive Results for its SugarBEAT® European Clinical Program. 2018-05-26. en-IN.
  14. Web site: Non-Invasive Blood Glucose Monitoring Devices Market Global Shares – Healthcare News. journalhealthcare.com. en-US. 2018-05-26.
  15. News: Wireless diabetes sensor patch heads for clinical trials. 2017-08-02. eeNews Europe. 2018-05-26. en.
  16. Web site: NEMAURA MEDICAL, INC. (OTCMKTS:NMRD) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive. marketexclusive.com. en-US. 2018-05-26.
  17. News: Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018. 2018-05-26. en-IN.
  18. Web site: Bashir Timol from Nemaura Medical speaking at NASDAQ Closing Bell Ringing Ceremony. NASDAQ 2018-03-06. 2018-06-18.
  19. Web site: MarketScreener . 2023-04-07 . NEMAURA MEDICAL INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K) . 2023-09-10 . MarketScreener . en-US.
  20. Web site: MIAX Exchange Group - Options Markets - Delisting of Nemaura Medical Inc. (NMRD) MIAX . 2024-01-11 . www.miaxglobal.com . en.

External links

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Nemaura Medical".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.